Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03590890

Ligand	Ligand name	Chain	PDB	Tanimoto
SIO	methyl 4,9-di-O-acetyl-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid	A	3CL5	0.72
AMN	9-DEOXY-9-AMINO-2-O-METHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID	A,B,C,D,E,F	1HGJ	0.72
GDL	2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE	A,B	1UR9	0.7
GDL	2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE	A,B,C,D,E,F	1O7A	0.7
GDL	2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE	A,B	1UR8	0.7
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,X	2F2L	0.76
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,B,C,D	2CB3	0.76
ABW	5-[1-(ACETYLAMINO)-3-METHYLBUTYL]-2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID	A	1XOG	0.71
AMV	METHYL 2-(ACETYLAMINO)-3-O-[(1R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSIDE	A	2J8G	0.73
AMV	METHYL 2-(ACETYLAMINO)-3-O-[(1R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSIDE	A	2J8F	0.73
ANA	4-O-ACETYL-ALPHA-2-OMETHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID	A,B,C,D,E,F	1HGI	0.71
GTH	3-O-GLUCOPYRANOSYL-THREONINE-[2-DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE]	A	1WCT	0.75
AB9	(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE	A,D,M,N,Z	2F4V	0.71
AB9	(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE	B	2F4T	0.71
AH0	2-(2-ACETYLAMINO-4-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCT-3-YLOXY)-PROPIONIC ACID	A	1QTE	0.72
SLT	5-(ACETYLAMINO)-3,5-DIDEOXYNON-2-ULOPYRANONOSYL-(2->3)-BETA-D-LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE	A	1S0I	0.71
SLT	5-(ACETYLAMINO)-3,5-DIDEOXYNON-2-ULOPYRANONOSYL-(2->3)-BETA-D-LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE	A	1Z4X	0.71
GSL	(2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA-D-GALACTOPYRANOSIDURONIC ACID	A	2FIK	0.75
NXD	METHYL 5-(ACETYLAMINO)-9-{[AMINO(OXO)ACETYL]AMINO}-3,5,9-TRIDEOXY-D-GLYCERO-ALPHA-D-GLUCO-NON-2-ULOPYRANOSIDONIC ACID	A	2G5R	0.75
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	2SLI	0.71
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	2JKB	0.71
SKD	2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID	A	3SLI	0.71
MGU	2-O-[2-O-METHYL-4-[2,4-DIHYDROXY-BUTYRAMIDO]-4,6-DIDEOXY-]-ALPHA-D-MANNOPYRANOSYL-[1-O-METHYL-4-[2,4-DIHYDROXY-BUTYRAMIDO]-4,6-DIDEOXY]-ALPHA-D-MANNOPYRANOSE	H	1F4Y	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	A,B,C,D	2APH	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	A,P	1TWQ	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	A	1D0K	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	S	9LYZ	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	E,S	148L	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	D,K	3CYQ	0.71
AMU	BETA-N-ACETYLMURAMIC ACID	U	2AIZ	0.71
2G0	(2S)-1-[(2S)-6-amino-2-({[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]acetyl}amino)hexanoyl]-N-[(1S)-1-carbamoyl-3-methylbutyl]pyrrolidine-2-carboxamide	A,B,C,D	3DCQ	0.7
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3I	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	1KQR	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B,C,D,E,F	1HGH	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B	2I2S	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3J	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A,B,C,D,E,F	1HGE	0.71
MNA	2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID	A	2P3K	0.71
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXV	0.77
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXU	0.77
MUB	N-ACETYLMURAMIC ACID	L,N	1WCO	0.71